by John Conrad | Oct 30, 2024 | iBIO News
The path to STEM careers often begins with early exposure and encouragement. For girls in underserved communities, access to engaging STEM education can be transformative, opening doors to future opportunities that might otherwise remain closed. iBIO’s STEMgirls...
by John Conrad | Oct 21, 2024 | iBIO News
Bristol Myers Squibb-sponsored kits will be distributed to 4th-8th graders at Frank W. Gunsaulus Scholastic Academy CHICAGO, IL – October 21, 2024 – The Illinois Biotechnology Innovation Organization (iBIO) is partnering with Bristol Myers Squibb (BMS) to...
by John Conrad | Oct 16, 2024 | iBIO News
In the heart of the Midwest, a technological revolution is brewing that could transform the landscape of pharmaceutical research. Chicago, long known for its towering skyscrapers and deep-dish pizza, is now poised to become the epicenter of a quantum-powered...
by John Conrad | Sep 17, 2024 | iBIO News
We are thrilled to announce the successful completion of the EPIC (Employer Provided Innovation Challenges) project, an initiative driven by the US Chamber of Commerce Foundation designed to provide students with hands-on, real-world learning experiences. In...
by John Conrad | Sep 10, 2024 | iBIO News, Policy News
iBIO has joined forces with fellow members of the Council of State Bioscience Associations (CSBA) in a crucial initiative to safeguard the future of rare pediatric disease research and treatment. Yesterday, our coalition sent a letter to congressional leaders, urging...
by John Conrad | Sep 9, 2024 | iBIO News
Amy Tomasulo battles trigeminal neuralgia, a rare neurological disorder that inflicts some of the most excruciating pain known to medicine. Diagnosed in 2001, she lives with a condition that affects approximately 400,000 Americans, causing intense, shock-like facial...